Michael M. Givertz, M.D. is Medical Director of the Heart Transplant and Mechanical Circulatory Support Program at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. His research interests include cardiorenal syndrome and novel therapies for advanced heart disease. He is a past research fellow of the American Heart Association and recipient of a career development award from the National Institutes of Health. He is a principal investigator in the NHLBI HeartShare Program, and has been a co-investigator in several other NIH-funded programs, including the NIAID Clinical Trials in Organ Transplantation, NIH Peripartum Cardiomyopathy Network and NHLBI Heart Failure Network. He is the current chair of the Research Committee and past chair of the Scientific Statements Committee of the Heart Failure Society of America, co-author of the 2017 ACCF/AHA/HFSA Guideline for the Management of Heart Failure, lead author of the 2019 AHA/HFSA Scientific Statement on Diabetes and Heart Failure, and co-chair of the 2022 ISHLT/HFSA Guideline on Acute Mechanical Circulatory Support. He has published widely on heart failure pathophysiology and management, with a focus on advanced heart disease, heart transplant and mechanical circulatory support.